Conference
Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis
Abstract
OBJECTIVE: Diffuse cutaneous systemic sclerosis (SSc) is a highly heterogeneous disease. A provisionally approved Composite Response Index in diffuse cutaneous SSc (CRISS) was developed as a 1-year outcome measure for clinical trials. Our goal was to further validate the CRISS by examining agreement between CRISS definitions for improved/non-improved with physicians' evaluation of disease.
METHODS: Patient profiles from a large observational …
Authors
Zheng B; Wang M; McKenna K; Shapiro L; Silver R; Csuka ME; van den Hoogen F; Robinson D; Pauling JD; Hummers L
Volume
74
Pagination
pp. 1806-1812
Publisher
Wiley
Publication Date
November 2022
DOI
10.1002/acr.24638
Conference proceedings
Arthritis Care & Research
Issue
11
ISSN
2151-464X